A harmless high?

The Lancet

Volumn 376, Issue 9742, 2010, Pages 742-

  Sammler, Esther M ^a   Foley, Peter L ^a   Lauder, Gavin D ^a   Wilson, Simon J ^a   Goudie, Andrew R ^a   O'Riordan, Jonathan I ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHINONE; MEPHEDRONE; UNCLASSIFIED DRUG; 4' METHYLMETHCATHINONE; CENTRAL STIMULANT AGENT; DESIGNER DRUG; METHAMPHETAMINE;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CASE REPORT; DRUG INTOXICATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INTRACRANIAL PRESSURE; MASS SPECTROMETRY; MEPHEDRONE INDUCED EUVOLEMIC HYPO OSMOTIC HYPONATREMIA; PRIORITY JOURNAL; URINALYSIS; ANALOGS AND DERIVATIVES; NEUROTOXICITY SYNDROMES;

ADOLESCENT; CENTRAL NERVOUS SYSTEM STIMULANTS; DESIGNER DRUGS; FEMALE; HUMANS; METHAMPHETAMINE; NEUROTOXICITY SYNDROMES;

EID: 77956245283     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60891-4     Document Type: Article

References (5)

1. Wood DM, Davies S, Puchnaewicz M, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol (in press) DOI:10.1007/s13181-010-0018-5.
2. Winstock AR, Marsden J, Mitcheson L. What should be done about mephedrone? BMJ; 340: c1605.
3. -2010 No. 1207 DANGEROUS DRUGS. The Misuse of Drugs Act 1971 (Amendment) Order 2010 http://www.opsi.gov.uk/si/si2010/pdf/uksi-20101207-en.pdf (accessed Aug 3, 2010).
4. J Rosenson, C Smollin, KA Sporer, P Blanc, KR Olson Patterns of ecstasy-associated hyponatremia in California Ann Emerg Med 49 2007 164 171 71 e1.
5. JA Henry, JK Fallon, AT Kicman, AJ Hutt, DA Cowan, M Forsling Low-dose MDMA ("ecstasy") induces vasopressin secretion Lancet 351 1998 1784